$QTWO
Q2 Holdings, Inc. Stock $qtwo

$qtwo Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000141038415000081 Filed on May 08, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q1
Revenue	$26.28M	$24.16M	$16.83M
YoY Change	37.2%	43.5%	31.17%
Cost Of Revenue	$14.14M	$13.27M	$10.21M
YoY Change	30.54%	29.96%	30.81%
Gross Profit	$12.15M	$10.89M	$6.622M
YoY Change	45.85%	64.38%	31.73%
Gross Profit Margin	46.21%	45.06%	39.34%
Selling, General & Admin	$12.33M	$11.32M	$9.227M
YoY Change	22.21%	22.67%	71.03%
% of Gross Profit	101.52%	103.99%	139.34%
Research & Development	$4.797M	$4.151M	$2.736M
YoY Change	72.12%	51.72%	46.62%
% of Gross Profit	39.49%	38.14%	41.32%
Depreciation & Amortization	$1.360M	$1.203M	$999.0K
YoY Change	31.91%	20.42%	56.58%
% of Gross Profit	11.2%	11.05%	15.09%
Operating Expenses	$17.13M	$15.47M	$11.96M
YoY Change	33.01%	29.32%	64.76%
Operating Profit	-$4.982M	-$4.585M	-$5.341M
YoY Change	9.52%	-14.15%	139.08%
Interest Expense	$0.00	$0.00	-$200.0K
YoY Change	-100.0%	-100.0%	100.0%
% of Operating Profit
Other Income/Expense, Net	$12.00K	-$28.00K	-$207.0K
YoY Change	-110.08%	-86.47%	305.88%
Pretax Income	-$4.970M	-$4.613M	-$5.548M
YoY Change	6.47%	-16.85%	142.8%
Income Tax	$12.00K	$32.00K	$18.00K
% Of Pretax Income
Net Earnings	-$4.982M	-$4.645M	-$5.566M
YoY Change	6.38%	-16.55%	123.62%
Net Earnings / Revenue	-18.95%	-19.23%	-33.06%
Basic Earnings Per Share
Diluted Earnings Per Share	-$134.4K	-$129.2K	-$397.2K
COMMON SHARES
Basic Shares Outstanding	37.19M shares	34.94M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$118.5M	$119.7M	$86.70M
YoY Change	24.87%	38.06%
Cash & Equivalents	$69.37M	$94.17M	$86.67M
Short-Term Investments	$49.20M	$25.50M
Other Short-Term Assets	$10.20M	$10.30M	$7.000M
YoY Change	41.67%	47.14%
Inventory
Prepaid Expenses
Receivables	$6.987M	$7.225M	$5.735M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$135.7M	$137.2M	$99.34M
YoY Change	26.17%	38.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.72M	$19.00M	$14.30M
YoY Change	33.45%	32.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.187M	$1.141M	$751.0K
YoY Change	60.41%	51.93%
Total Long-Term Assets	$34.02M	$33.89M	$26.20M
YoY Change	30.89%	29.37%
TOTAL ASSETS
Total Short-Term Assets	$135.7M	$137.2M	$99.34M
Total Long-Term Assets	$34.02M	$33.89M	$26.20M
Total Assets	$169.7M	$171.0M	$125.5M
YoY Change	27.09%	36.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.527M	$3.444M	$4.501M
YoY Change	81.9%	-23.48%
Accrued Expenses	$6.870M	$10.34M	$5.855M
YoY Change	2.49%	76.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$300.0K	$600.0K
YoY Change	-40.0%	-50.0%
Total Short-Term Liabilities	$32.53M	$35.48M	$24.22M
YoY Change	38.41%	46.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$100.0K	$6.323M
YoY Change	-100.0%	-98.42%
Other Long-Term Liabilities	$720.0K	$709.0K	$69.00K
YoY Change	10185.71%	927.54%
Total Long-Term Liabilities	$720.0K	$709.0K	$6.392M
YoY Change	-65.07%	-88.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.53M	$35.48M	$24.22M
Total Long-Term Liabilities	$720.0K	$709.0K	$6.392M
Total Liabilities	$63.41M	$61.82M	$50.96M
YoY Change	30.05%	21.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.99M	-$69.01M	-$50.30M
YoY Change	34.58%	37.2%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$27.00K	$27.00K
YoY Change
Treasury Stock Shares	1.000K shares	1.000K shares
Shareholders Equity	$106.3M	$109.2M	$74.58M
YoY Change
Total Liabilities & Shareholders Equity	$169.7M	$171.0M	$125.5M
YoY Change	27.09%	36.25%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$4.982M	-$4.645M	-$5.566M
YoY Change	6.38%	-16.55%	123.62%
Depreciation, Depletion And Amortization	$1.360M	$1.203M	$999.0K
YoY Change	31.91%	20.42%	56.58%
Cash From Operating Activities	$2.970M	-$2.644M	-$4.498M
YoY Change	661.54%	-41.22%	175.44%
INVESTING ACTIVITIES
Capital Expenditures	-$1.880M	$436.0K	$1.830M
YoY Change	193.75%	-76.17%	-27.98%
Acquisitions		$0.00
YoY Change
Other Investing Activities	-$23.57M	-$4.650M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$25.46M	-$5.086M	-$1.830M
YoY Change	3878.12%	177.92%	-32.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.320M	$33.92M	$74.33M
YoY Change	-127.36%	-54.36%	292.28%
NET CHANGE
Cash From Operating Activities	2.970M	-$2.644M	-$4.498M
Cash From Investing Activities	-25.46M	-$5.086M	-$1.830M
Cash From Financing Activities	-2.320M	$33.92M	$74.33M
Net Change In Cash	-24.81M	$26.19M	$68.00M
YoY Change	-401.46%	-61.48%	365.68%
FREE CASH FLOW
Cash From Operating Activities	$2.970M	-$2.644M	-$4.498M
Capital Expenditures	-$1.880M	$436.0K	$1.830M
Free Cash Flow	$4.850M	-$3.080M	-$6.328M
YoY Change	370.87%	-51.33%	51.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001410384
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37188805	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	Q2 HOLDINGS, INC.
CY2015Q1	dei	Trading Symbol TradingSymbol	qtwo
CY2014Q4	qtwo	Allowancefor Sales Credits AllowanceforSalesCredits	200000	USD
CY2015Q1	qtwo	Allowancefor Sales Credits AllowanceforSalesCredits	200000	USD
CY2014Q4	qtwo	Availableforsale Securities Debt Maturities After Twelve Months Fair Value AvailableforsaleSecuritiesDebtMaturitiesAfterTwelveMonthsFairValue	11861000	USD
CY2015Q1	qtwo	Availableforsale Securities Debt Maturities After Twelve Months Fair Value AvailableforsaleSecuritiesDebtMaturitiesAfterTwelveMonthsFairValue	12776000	USD
CY2014Q1	qtwo	Convertible Stock Shares Issued Upon Conversion ConvertibleStockSharesIssuedUponConversion	1	shares
CY2014Q4	qtwo	Deferred Implementation Costs Current DeferredImplementationCostsCurrent	1996000	USD
CY2015Q1	qtwo	Deferred Implementation Costs Current DeferredImplementationCostsCurrent	2054000	USD
CY2014Q4	qtwo	Deferred Implementation Costs Noncurrent DeferredImplementationCostsNoncurrent	5378000	USD
CY2015Q1	qtwo	Deferred Implementation Costs Noncurrent DeferredImplementationCostsNoncurrent	5554000	USD
CY2014Q4	qtwo	Deferred Sales Commissions Currentand Noncurrent DeferredSalesCommissionsCurrentandNoncurrent	7000000	USD
CY2015Q1	qtwo	Deferred Sales Commissions Currentand Noncurrent DeferredSalesCommissionsCurrentandNoncurrent	7500000	USD
CY2014Q4	qtwo	Deferred Solution Costs Current DeferredSolutionCostsCurrent	5060000	USD
CY2015Q1	qtwo	Deferred Solution Costs Current DeferredSolutionCostsCurrent	4070000	USD
CY2014Q4	qtwo	Deferred Solution Costs Noncurrent DeferredSolutionCostsNoncurrent	7159000	USD
CY2015Q1	qtwo	Deferred Solution Costs Noncurrent DeferredSolutionCostsNoncurrent	8192000	USD
CY2014Q1	qtwo	Implementation Costs Capitalized ImplementationCostsCapitalized	800000	USD
CY2015Q1	qtwo	Implementation Costs Capitalized ImplementationCostsCapitalized	900000	USD
CY2014Q1	qtwo	Increase Decreasein Deferred Implementation Costs IncreaseDecreaseinDeferredImplementationCosts	837000	USD
CY2015Q1	qtwo	Increase Decreasein Deferred Implementation Costs IncreaseDecreaseinDeferredImplementationCosts	918000	USD
CY2014Q1	qtwo	Increase Decreasein Deferred Solutionand Other Costs IncreaseDecreaseinDeferredSolutionandOtherCosts	1467000	USD
CY2015Q1	qtwo	Increase Decreasein Deferred Solutionand Other Costs IncreaseDecreaseinDeferredSolutionandOtherCosts	488000	USD
CY2014Q1	qtwo	Interestand Other Expense Nonoperating InterestandOtherExpenseNonoperating	207000	USD
CY2015Q1	qtwo	Interestand Other Expense Nonoperating InterestandOtherExpenseNonoperating	72000	USD
CY2014Q3	qtwo	Lease Agreement Square Footage LeaseAgreementSquareFootage	70000	sqft
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1986000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3444000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5007000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7225000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9268000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10338000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	143337000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178262000	USD
CY2014Q1	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2015Q1	us-gaap	Advertising Expense AdvertisingExpense	100000	USD
CY2014Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	24000	USD
CY2015Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	24000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18804000	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5927000	shares
CY2014Q4	us-gaap	Assets Assets	136806000	USD
CY2015Q1	us-gaap	Assets Assets	171043000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	104522000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	137155000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	20956000	USD
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	25525000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	14000	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	20970000	USD
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	25529000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	14000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	4000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	13708000	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	18873000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	20956000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	25525000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	9095000	USD
CY2015Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	12749000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	408000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	338000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	167000	USD
CY2015Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	105000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18675000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94170000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	67998000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86673000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67979000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	961000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2876000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-363000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-41000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	193000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-190000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	695000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	26191000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34697000	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37189000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34696000	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37188000	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	3000	USD
CY2015Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	4000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	10212000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	13272000	USD
CY2014Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	3936000	USD
CY2015Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	2781000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4694000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4504000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17289000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	18576000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	19436000	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	21025000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	999000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1203000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003
CY2015Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14800000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3718000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5125000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	6622000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	10885000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5548000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4613000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1038000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	917000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3314000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2232000	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4725000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1200000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	102000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	585000	USD
CY2014Q1	us-gaap	Interest Income Other InterestIncomeOther	0	USD
CY2015Q1	us-gaap	Interest Income Other InterestIncomeOther	44000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	23000	USD
CY2014Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	0	USD
CY2015Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	89000	USD
CY2014Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2015Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	57866000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	61820000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	136806000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171043000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32887000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	35477000	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	20956000	USD
CY2015Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	25525000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	74326000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33921000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1830000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5086000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4498000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2644000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-5566000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-4645000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-207000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-28000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	11963000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	15470000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5341000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4585000	USD
CY2014Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	967000	USD
CY2015Q1	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	1127000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1226000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1141000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5566000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4636000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	9000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	682000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	709000	USD
CY2014Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2015Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7000	USD
CY2014Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2015Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	6480000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1830000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	436000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2695000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3282000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	72600000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	73615000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	32811000	USD
CY2014Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	12500000	USD
CY2015Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1830000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	934000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1253000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18521000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19001000	USD
CY2014Q1	us-gaap	Reimbursement Revenue ReimbursementRevenue	100000	USD
CY2015Q1	us-gaap	Reimbursement Revenue ReimbursementRevenue	200000	USD
CY2014Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	12500000	USD
CY2015Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2014Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	223000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	136000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2736000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4151000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	829000	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	829000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64366000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69011000	USD
CY2014Q1	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	-15000	USD
CY2015Q1	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	-15000	USD
CY2014Q1	us-gaap	Revenues Revenues	16834000	USD
CY2015Q1	us-gaap	Revenues Revenues	24157000	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5509000	USD
CY2015Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6194000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	918000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1322000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.452
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.469
CY2015Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2015Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	7.36
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1100000	USD
CY2015Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.12
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.71
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.58
CY2015Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.25
CY2015Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2367000	shares
CY2015Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	5702000	shares
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y9M18D
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	400000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.451
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.461
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.021
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.012
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7500000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13300000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	49000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	375000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.39
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.25
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6111000	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5702000	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.90
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.36
CY2015Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y7M6D
CY2015Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	735000	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	78940000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	109223000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1000	shares
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1000	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	20000	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	27000	USD
CY2014Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2300000	USD
CY2015Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2900000	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14107000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35633000	shares
CY2015Q1	us-gaap	Advertising Cost Policy Expensed Advertising Cost AdvertisingCostPolicyExpensedAdvertisingCost	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Advertising</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All advertising costs of the Company are expensed the first time the advertising takes place.</font></div></div>
CY2015Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, restricted cash, investments and accounts receivable. The Company's cash and cash equivalents and restricted cash are placed with high credit quality financial institutions and issuers, and at times may exceed federally-insured limits. The Company has not experienced any loss relating to cash and cash equivalents or restricted cash in these accounts. The Company provides credit, in the normal course of business, to a number of its customers. The Company performs periodic credit evaluations of its customers' financial condition and generally does not require collateral. </font></div></div>
CY2015Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Deferred Revenues</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenues primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments received from customers in advance for implementation, maintenance and other services, as well as initial subscription fees. The Company recognizes deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed. Deferred revenues that are expected to be recognized as revenues during the succeeding twelve month period are recorded in current liabilities as deferred revenues, current portion and the remaining portion is recorded in long-term liabilities as deferred revenues, net of current portion.</font></div></div>
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the accompanying interim unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the interim unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses. Significant items subject to such estimates include stock-based compensation, the useful lives of property and equipment and income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001410384-15-000081-index-headers.html	Edgar Link	pending
0001410384-15-000081-index.html	Edgar Link	pending
0001410384-15-000081.txt	Edgar Link	pending
0001410384-15-000081-xbrl.zip	Edgar Link	pending
a3311510q.htm	Edgar Link	pending
a3312015exhibit311.htm	Edgar Link	pending
a3312015exhibit312.htm	Edgar Link	pending
a3312015exhibit321.htm	Edgar Link	pending
a3312015exhibit322.htm	Edgar Link	pending
exhbit101.htm	Edgar Link	pending
exhibit102.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
qtwo-20150331.xml	Edgar Link	completed
qtwo-20150331.xsd	Edgar Link	pending
qtwo-20150331_cal.xml	Edgar Link	unprocessable
qtwo-20150331_def.xml	Edgar Link	unprocessable
qtwo-20150331_lab.xml	Edgar Link	unprocessable
qtwo-20150331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QTWO
Q2 Holdings, Inc. Stock $qtwo

2015 Q2 Form 10-Q Financial Statement

#000141038415000081 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QTWO Q2 Holdings, Inc. Stock $qtwo

2015 Q2 Form 10-Q Financial Statement

#000141038415000081 Filed on May 08, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QTWO
Q2 Holdings, Inc. Stock $qtwo